Skip to main content
SpringerLink
Log in

Der Stellenwert der Operation bei der Behandlung des resektablen nicht-kleinzelligen Lungenkarzinoms im Stadium III

The role of surgery for the management of resectable stage III non-small cell lung cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Mountain CF (1997) Revisions in the International System for Lung Cancer. Chest 111:1710–1717

    Article  CAS  PubMed  Google Scholar 

  2. Eberhardt WE, Pöttgen C, Gauler TC et al (2015) Phase III study of surgery versus definitive concurrent Chemoradiotherapy boost in patients with Resectable stage IIIA(N2) and selected IIIB non-small-cell lung cancer after induction chemotherapy and concurrent Chemoradiotherapy (ESPATUE). J Clin Oncol 33:4194–4201

    Article  CAS  PubMed  Google Scholar 

  3. Meerbeeck JP van, Kramer GW, Van Schil PE et al (2007) Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. Journal of the National Cancer Institute 99:442–450

    Article  PubMed  Google Scholar 

  4. Vokes EE, Herndon J 2nd, Kelley MJ et al (2007) Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25:1698–1704

    Article  CAS  PubMed  Google Scholar 

  5. El-Sharouni SY, Kal HB, Battermann JJ, Schramel FM (2006) Sequential versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer. Anticancer Res 26:495–505

    CAS  PubMed  Google Scholar 

  6. Zhang W, Liu Q, Dong X, Lei P (2015) A meta-analysis comparing hyperfractionated vs. conventional fractionated radiotherapy in non-small cell lung cancer. J Thorac Dis 7:478–485

    PubMed  PubMed Central  Google Scholar 

  7. Eberhardt WE, Gauler TC, Lepechoux C et al (2013) 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL). Lung Cancer 82:83–89

    Article  PubMed  Google Scholar 

  8. Albain KS, Swann RS, Rusch VR et al (2009) Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 374:379–386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hanna N, Neubauer M, Yiannoutsos C et al (2008) Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755–5760

    Article  CAS  PubMed  Google Scholar 

  10. Ren Z, Zhou S, Liu Z, Xu S (2015) Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis. J Thorac Dis 7:1414–1422

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lehrstuhl für Strahlentherapie, Medizinische Universität Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland

    Dirk Rades

Authors
  1. Dirk Rades
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirk Rades.

Additional information

Originalpublikation Eberhardt WE, Pöttgen C, Gauler TC et al (2015) Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non-small-cell lung cancer after induction chemotherapy and concurrent chemoradiotherapy (ESPATUE). J Clin Oncol 33:4194–4201

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rades, D. Der Stellenwert der Operation bei der Behandlung des resektablen nicht-kleinzelligen Lungenkarzinoms im Stadium III. Strahlenther Onkol 192, 592–594 (2016). https://doi.org/10.1007/s00066-016-1001-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1001-0

Search

Navigation